SEC Form 4 · accession 0001209191-18-050075
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip D Gregory
Officer — Chief Scientific Officer
Period of report
Sep 5, 2018
Accepted (ET)
Sep 7, 2018 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 5, 2018 | M | 600 | $50.51 | A | 32,971 | D | |
| Common Stock | Sep 5, 2018 | M | 700 | $75.60 | A | 33,671 | D | |
| Common StockF2 | Sep 5, 2018 | S | 777 | $161.8295 | D | 32,894 | D | |
| Common StockF3 | Sep 5, 2018 | S | 510 | $162.9039 | D | 32,384 | D | |
| Common StockF4 | Sep 5, 2018 | S | 213 | $164.0317 | D | 32,171 | D | |
| Common StockF5 | Sep 5, 2018 | S | 200 | $165.275 | D | 31,971 | D | |
| Common Stock | Sep 5, 2018 | S | 100 | $166.25 | D | 31,871 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $50.51 | Sep 5, 2018 | M | 600 | D | — | Mar 1, 2026 | Common Stock | 600 | 15,800 | D |
| Stock Option (right to buy)F7 | $75.60 | Sep 5, 2018 | M | 700 | D | — | Feb 1, 2027 | Common Stock | 700 | 32,700 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- F2The range in prices for the transaction reported on this line was $161.25 to $162.15. The average weighted price was $161.8295. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $162.50 to $163.45. The average weighted price was $162.9039. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range in prices for the transaction reported on this line was $163.60 to $164.50. The average weighted price was $164.0317. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range in prices for the transaction reported on this line was $165.05 to $165.50. The average weighted price was $165.2750. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017 and in 36 equal monthly installments thereafter.
- F7This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2018 and in 36 equal monthly installments thereafter.